![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | decreases expression | ISO | RGD:1307757 | 6480464 | o more ... | CTD | PMID:22937105 | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | ISO | RGD:1317132 | 6480464 | o, p'-DDT results in increased expression of SPHK2 mRNA | CTD | PMID:24096037 | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | ISO | RGD:1307757 | 6480464 | o, p'-DDT results in increased expression of SPHK2 mRNA | CTD | PMID:24096037 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1317132 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SPHK2 mRNA | CTD | PMID:22206623 | 1H-pyrazole | decreases expression | ISO | RGD:1317132 | 6480464 | pyrazole results in decreased expression of SPHK2 mRNA | CTD | PMID:17945193 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | RGD:1307757 | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1307757 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SPHK2 mRNA | CTD | PMID:19520675 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1317132 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SPHK2 mRNA | CTD | PMID:28213091 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1317132 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SPHK2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1307757 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SPHK2 mRNA | CTD | PMID:21215274 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1307757 | 6480464 | AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of SPHK2 mRNA] | CTD | PMID:21215274 | 2,4-dinitrotoluene | affects expression | ISO | RGD:1307757 | 6480464 | 2, 4-dinitrotoluene affects the expression of SPHK2 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | ISO | RGD:1307757 | 6480464 | 2, 6-dinitrotoluene affects the expression of SPHK2 mRNA | CTD | PMID:21346803 | 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | RGD:1317132 | 6480464 | tetrabromobisphenol A results in increased expression of SPHK2 mRNA | CTD | PMID:25172293 | 4-amino-2,6-dinitrotoluene | affects expression | ISO | RGD:1307757 | 6480464 | 4-amino-2, 6-dinitrotoluene affects the expression of SPHK2 mRNA | CTD | PMID:21346803 | acrylamide | increases expression | ISO | RGD:1307757 | 6480464 | Acrylamide results in increased expression of SPHK2 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases expression | ISO | RGD:1317132 | 6480464 | Aflatoxin B1 results in increased expression of SPHK2 mRNA | CTD | PMID:19770486 | Aroclor 1254 | increases expression | ISO | RGD:1317132 | 6480464 | Chlorodiphenyl 54% Chlorine results in increased expression of SPHK2 mRNA | CTD | PMID:23650126 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of SPHK2 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzoapyrene results in decreased expression of SPHK2 mRNA | CTD | PMID:26238291 | bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:1317132 | 6480464 | Mustard Gas results in increased expression of SPHK2 mRNA | CTD | PMID:15674844 | bisphenol A | increases expression | ISO | RGD:1317132 | 6480464 | bisphenol A results in increased expression of SPHK2 mRNA | CTD | PMID:31453682 | Brodifacoum | decreases expression | ISO | RGD:1307757 | 6480464 | bromfenacoum results in decreased expression of SPHK2 protein | CTD | PMID:28903499 | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of SPHK2 mRNA | CTD | PMID:26079696 | carbon nanotube | increases expression | ISO | RGD:1317132 | 6480464 | Nanotubes, Carbon results in increased expression of SPHK2 mRNA | CTD | PMID:25620056 | choline | multiple interactions | ISO | RGD:1317132 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SPHK2 gene | CTD | PMID:20938992 | cobalt dichloride | increases response to substance | ISO | RGD:1317132 | 6480464 | SPHK2 results in increased susceptibility to cobaltous chloride | CTD | PMID:23043544 | decabromodiphenyl ether | increases expression | ISO | RGD:1307757 | 6480464 | decabromobiphenyl ether results in increased expression of SPHK2 mRNA | CTD | PMID:23640034 | dioxygen | increases response to substance | ISO | RGD:1317132 | 6480464 | SPHK2 results in increased susceptibility to Oxygen deficiency | CTD | PMID:23043544 | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of SPHK2 mRNA | CTD | PMID:18175754 | doxorubicin | multiple interactions | EXP | | 6480464 | SPHK2 protein affects the reaction [Doxorubicin results in increased expression of CDKN1A protein] | CTD | PMID:17974990 | doxorubicin | increases response to substance | EXP | | 6480464 | SPHK2 protein results in increased susceptibility to Doxorubicin | CTD | PMID:17974990 | ethanol | multiple interactions | ISO | RGD:1317132 | 6480464 | [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of SPHK2 mRNA | CTD | PMID:30517762 | ethanol | affects expression | ISO | RGD:1317132 | 6480464 | Ethanol affects the expression of SPHK2 mRNA | CTD | PMID:30319688 | finasteride | increases expression | ISO | RGD:1307757 | 6480464 | Finasteride results in increased expression of SPHK2 mRNA | CTD | PMID:24136188 | fingolimod hydrochloride | increases phosphorylation | EXP | | 6480464 | SPHK2 protein results in increased phosphorylation of Fingolimod Hydrochloride | CTD | PMID:24859201 | fingolimod hydrochloride | multiple interactions | EXP | | 6480464 | Fingolimod Hydrochloride inhibits the reaction [SPHK2 protein results in increased expression of S1PR1 protein], SPHK2 protein promotes the reaction [Fingolimod Hydrochloride metabolite binds to HDAC1 protein] | CTD | PMID:24859201 | fingolimod hydrochloride | increases response to substance | ISO | RGD:1317132 | 6480464 | SPHK2 results in increased susceptibility to Fingolimod Hydrochloride | CTD | PMID:23043544 | flutamide | increases expression | ISO | RGD:1307757 | 6480464 | Flutamide results in increased expression of SPHK2 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | RGD:1317132 | 6480464 | [1 more ... | CTD | PMID:20938992, PMID:22206623 | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of SPHK2 mRNA | CTD | PMID:20044591 | isobutanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SPHK2 mRNA | CTD | PMID:29432896 | isoprenaline | decreases expression | ISO | RGD:1317132 | 6480464 | Isoproterenol results in decreased expression of SPHK2 mRNA | CTD | PMID:20003209 | L-methionine | multiple interactions | ISO | RGD:1317132 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SPHK2 gene | CTD | PMID:20938992 | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of SPHK2 mRNA | CTD | PMID:22313790 | lead(2+) | affects expression | EXP | | 6480464 | Lead affects the expression of SPHK2 mRNA | CTD | PMID:22313790 | methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of SPHK2 mRNA | CTD | PMID:17400583 | nefazodone | increases expression | ISO | RGD:1307757 | 6480464 | nefazodone results in increased expression of SPHK2 mRNA | CTD | PMID:24136188 | nickel dichloride | affects expression | ISO | RGD:1307757 | 6480464 | nickel chloride affects the expression of SPHK2 mRNA | CTD | PMID:22546817 | phenobarbital | decreases expression | ISO | RGD:1317132 | 6480464 | Phenobarbital results in decreased expression of SPHK2 mRNA | CTD | PMID:19270015 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SPHK2 mRNA | CTD | PMID:19710929 | pirinixic acid | decreases expression | ISO | RGD:1317132 | 6480464 | pirinixic acid results in decreased expression of SPHK2 mRNA | CTD | PMID:17426115 | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:1317132 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of SPHK2 mRNA | CTD | PMID:28903501 | propiconazole | decreases expression | ISO | RGD:1317132 | 6480464 | propiconazole results in decreased expression of SPHK2 mRNA | CTD | PMID:21278054 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of SPHK2 mRNA | CTD | PMID:31533062 | tacrolimus hydrate | decreases expression | ISO | RGD:1317132 | 6480464 | Tacrolimus results in decreased expression of SPHK2 mRNA | CTD | PMID:25270620 | tetrachloromethane | increases expression | ISO | RGD:1317132 | 6480464 | Carbon Tetrachloride results in increased expression of SPHK2 mRNA | CTD | PMID:17341687 | tetrachloromethane | multiple interactions | ISO | RGD:1317132 | 6480464 | [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of SPHK2 mRNA | CTD | PMID:30517762 | titanium dioxide | decreases expression | ISO | RGD:1317132 | 6480464 | titanium dioxide results in decreased expression of SPHK2 mRNA | CTD | PMID:23409001 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of SPHK2 gene | CTD | PMID:29154799 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SPHK2 mRNA | CTD | PMID:25979313 | valproic acid | affects expression | ISO | RGD:1317132 | 6480464 | Valproic Acid affects the expression of SPHK2 mRNA | CTD | PMID:17292431 | vinclozolin | decreases expression | ISO | RGD:1307757 | 6480464 | vinclozolin results in decreased expression of SPHK2 mRNA | CTD | PMID:23034163 | |